SCHEMBL6174775

SCHEMBL6174775

CC(C)OC(=O)Nc1cnccc1CC1(C)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 1/20 0.38
FLT1 P17948 3/20 0.37
KDR P35968 3/20 0.37
TRPV1 Q8NER1 1/20 0.36
NAMPT P43490 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NTRK1 P04629 1/20 0.34
ABL1 P00519 6/20 0.33
DGAT2 Q96PD7 2/20 0.33
AR P10275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171757 0.89 CYP3A4 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6176657 0.88 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174742 0.88 IGF1R (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174680 0.87 IGF1R (0.37) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172191 0.86 AOC1 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173183 0.85 CYP3A4 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174981 0.85 CYP3A4 (0.51) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6277096 0.85 CYP3A4 (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175827 0.85 NPC1 (0.46) TRPV1NAMPTNPC1RAB9ADGAT2
SCHEMBL6708303 0.84 TRPV1 (0.50) ALDH1A1TRPV1NAMPTNTRK1DGAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed